Literature DB >> 31641066

Chronic kidney disease referrals from general practitioners pre- and post National Institute for Health and Care Excellence guidance 2014.

Aruna Arjunan1, Mohammad S Jeelani2, Sharon Docherty3, Jo Taylor2.   

Abstract

INTRODUCTION: Mortality from chronic kidney disease (CKD) is increasing. Most patients die from cardiovascular disease and management of cardiovascular risks is key to prevent both mortality and progression to end-stage renal disease. In 2014, the National Institute of Health and Care Excellence (NICE) introduced guidance to help general practitioners (GPs) manage CKD patients. AIM: We aimed to determine the impact of the updated CKD guidance on CKD/cardiovascular risks optimisation and the timeliness of referral from the primary care.
METHODS: All new GP referrals to the Regional Renal Service in 2012 and 2016 were analysed. Data were collected on patient age, estimated glomerular filtration rate (eGFR) at referral, blood pressure (BP), smoking, body mass index, glycated haemoglobin (HbA1c; in diabetic patients) and lipid assessment.
RESULTS: A total of 486 new GP referrals were received in 2012, and 574 in 2016 (18% increase post NICE CKD guideline). Post NICE, fewer stage 4 and 5 CKD patients were being referred. But late referrals (eGFR <20 mL/min/1.73 m2) were not improved. BP control had improved. More patients had cholesterol-levels checked. The number of smokers and obese patients had not improved.
CONCLUSION: Post NICE guidelines, GPs are better in optimising BP. Diabetes management and lifestyle modifications need further improvement.
© 2019 Royal College of Physicians.

Entities:  

Keywords:  Chronic kidney disease; NICE guidelines

Year:  2019        PMID: 31641066      PMCID: PMC6899234          DOI: 10.7861/clinmed.2019-0105

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  24 in total

1.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

Authors:  Kunihiro Matsushita; Marije van der Velde; Brad C Astor; Mark Woodward; Andrew S Levey; Paul E de Jong; Josef Coresh; Ron T Gansevoort
Journal:  Lancet       Date:  2010-05-17       Impact factor: 79.321

2.  CKD and Diabetes: What Can We Learn From Their Similarities and Differences?

Authors:  Andrew S Levey; Rudy Bilous; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2016-03       Impact factor: 8.860

Review 3.  Chronic Kidney Disease.

Authors:  Angela C Webster; Evi V Nagler; Rachael L Morton; Philip Masson
Journal:  Lancet       Date:  2016-11-23       Impact factor: 79.321

Review 4.  Importance of blood pressure control in chronic kidney disease.

Authors:  Maura Ravera; Michela Re; Luca Deferrari; Simone Vettoretti; Giacomo Deferrari
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

Review 5.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

6.  Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.

Authors:  J B Lewis; T Berl; R P Bain; R D Rohde; E J Lewis
Journal:  Am J Kidney Dis       Date:  1999-11       Impact factor: 8.860

7.  Progression of diabetic nephropathy in normotensive type 1 diabetic patients.

Authors:  P Jacobsen; K Rossing; L Tarnow; P Rossing; C Mallet; O Poirier; F Cambien; H H Parving
Journal:  Kidney Int Suppl       Date:  1999-07       Impact factor: 10.545

8.  Body mass index and risk for end-stage renal disease.

Authors:  Chi-yuan Hsu; Charles E McCulloch; Carlos Iribarren; Jeanne Darbinian; Alan S Go
Journal:  Ann Intern Med       Date:  2006-01-03       Impact factor: 25.391

Review 9.  Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Authors:  Ron T Gansevoort; Ricardo Correa-Rotter; Brenda R Hemmelgarn; Tazeen H Jafar; Hiddo J Lambers Heerspink; Johannes F Mann; Kunihiro Matsushita; Chi Pang Wen
Journal:  Lancet       Date:  2013-05-31       Impact factor: 79.321

10.  Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium.

Authors:  Alex R Chang; Morgan E Grams; Shoshana H Ballew; Henk Bilo; Adolfo Correa; Marie Evans; Orlando M Gutierrez; Farhad Hosseinpanah; Kunitoshi Iseki; Timothy Kenealy; Barbara Klein; Florian Kronenberg; Brian J Lee; Yuanying Li; Katsuyuki Miura; Sankar D Navaneethan; Paul J Roderick; Jose M Valdivielso; Frank L J Visseren; Luxia Zhang; Ron T Gansevoort; Stein I Hallan; Andrew S Levey; Kunihiro Matsushita; Varda Shalev; Mark Woodward
Journal:  BMJ       Date:  2019-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.